Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (207) 207
life sciences & biomedicine (202) 202
humans (159) 159
gastroenterology & hepatology (96) 96
male (86) 86
middle aged (78) 78
female (76) 76
hepatocellular carcinoma (64) 64
liver cancer (61) 61
oncology (57) 57
aged (56) 56
tumors (51) 51
liver neoplasms - therapy (49) 49
liver (48) 48
microspheres (43) 43
biological and medical sciences (42) 42
medical sciences (41) 41
carcinoma, hepatocellular - therapy (36) 36
adult (34) 34
surgery (33) 33
liver neoplasms - radiotherapy (31) 31
radioembolization (31) 31
liver neoplasms - pathology (28) 28
treatment outcome (28) 28
retrospective studies (27) 27
cancer (26) 26
embolization, therapeutic - methods (26) 26
gastroenterology. liver. pancreas. abdomen (26) 26
liver transplantation (26) 26
radiology, nuclear medicine & medical imaging (26) 26
animals (25) 25
liver. biliary tract. portal circulation. exocrine pancreas (25) 25
carcinoma, hepatocellular - pathology (24) 24
hepatoma (23) 23
transplantation (23) 23
patients (21) 21
liver neoplasms - mortality (20) 20
carcinoma, hepatocellular - radiotherapy (19) 19
care and treatment (19) 19
risk factors (19) 19
yttrium radioisotopes - therapeutic use (19) 19
abridged index medicus (18) 18
gene therapy (17) 17
immunotherapy (17) 17
selective internal radiation therapy (17) 17
analysis (16) 16
carcinoma, hepatocellular - mortality (16) 16
cardiovascular system & cardiology (16) 16
clinical trials (16) 16
prognosis (16) 16
yttrium-90 (16) 16
embolization, therapeutic - adverse effects (15) 15
gastroenterology and hepatology (15) 15
liver cirrhosis (15) 15
hepatology (14) 14
liver diseases (14) 14
survival (14) 14
embolization, therapeutic (13) 13
hepatic artery (13) 13
yttrium radioisotopes - administration & dosage (13) 13
chemotherapy (12) 12
follow-up studies (12) 12
genetic therapy - methods (12) 12
hemodynamics (12) 12
liver - pathology (12) 12
liver neoplasms (12) 12
metastases (12) 12
metastasis (12) 12
radiotherapy (12) 12
sirt (12) 12
survival rate (12) 12
genetic vectors (11) 11
health aspects (11) 11
liver neoplasms - blood supply (11) 11
liver neoplasms - drug therapy (11) 11
liver neoplasms - secondary (11) 11
liver neoplasms - surgery (11) 11
medicine & public health (11) 11
neoplasm staging (11) 11
safety (11) 11
sorafenib (11) 11
yttrium (11) 11
yttrium radioisotopes - adverse effects (11) 11
brachytherapy - methods (10) 10
engineering (10) 10
gene expression (10) 10
multivariate analysis (10) 10
adenoviridae - genetics (9) 9
aged, 80 and over (9) 9
carcinoma, hepatocellular - drug therapy (9) 9
cardiac & cardiovascular systems (9) 9
cholangiocarcinoma (9) 9
cirrhosis (9) 9
engineering, biomedical (9) 9
immunology (9) 9
liver neoplasms - genetics (9) 9
liver transplantation - adverse effects (9) 9
prospective studies (9) 9
rare earth metals (9) 9
technology (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Abstract IA25: Targeted therapies for hepatocellular carcinoma
by Sangro, Bruno
Cancer research (Chicago, Ill.), ISSN 0008-5472, 11/2017, Volume 77, Issue 22 Supplement, pp. IA25 - IA25
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Targets for immunotherapy of liver cancer
by Greten, Tim F and Sangro, Bruno
Journal of hepatology, ISSN 0168-8278, 01/2018, Volume 68, Issue 1, pp. 157 - 166
HCC | Immunotherapy | Cancer | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Clinical trials | Liver cancer | Hepatocellular carcinoma | Immune checkpoint | Drug development
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Immunological landscape and immunotherapy of hepatocellular carcinoma
by Prieto, Jesús and Melero, Ignacio and Sangro, Bruno
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5045, 12/2015, Volume 12, Issue 12, pp. 681 - 700
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Neoplasms - immunology | Immunotherapy - methods | Carcinoma, Hepatocellular - immunology | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Humans | Radiofrequency ablation | Usage | Care and treatment | Hepatoma | Immunotherapy | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Immunotherapy of hepatocellular carcinoma: Facts and hopes
by Iñarrairaegui, Mercedes and Melero, Ignacio and Sangro, Bruno
Clinical cancer research, ISSN 1078-0432, 04/2018, Volume 24, Issue 7, pp. 1518 - 1524
Life Sciences & Biomedicine | Oncology | Science & Technology | PD-1 protein | Clinical trials | Cytotoxicity | Hepatocellular carcinoma | Lymphocytes T | Patients | Immunosuppressive agents | Anticancer properties | Proteins | Liver cancer | CTLA-4 protein | Inhibitors | Immune checkpoint | Cell death | Immunotherapy | Monoclonal antibodies | Biomarkers | Antitumor activity | Synergistic effect | Tumors | Cancer | Apoptosis | Immune system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
by El-Khoueiry, Anthony B, Dr and Sangro, Bruno, MD and Yau, Thomas, MD and Crocenzi, Todd S, MD and Kudo, Masatoshi, MD and Hsu, Chiun, MD and Kim, Tae-You, MD and Choo, Su-Pin, BMBS and Trojan, Jörg, MD and Welling, Theodore H, MD and Meyer, Tim, MD and Kang, Yoon-Koo, MD and Yeo, Winnie, MD and Chopra, Akhil, MD and Anderson, Jeffrey, MD and dela Cruz, Christine, MD and Lang, Lixin, PhD and Neely, Jaclyn, PhD and Tang, Hao, PhD and Dastani, Homa B, PhD and Melero, Ignacio
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2492 - 2502
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Administration Schedule | Humans | Antibodies, Monoclonal - adverse effects | Liver Neoplasms - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Treatment Outcome | Antineoplastic Agents - administration & dosage | Tumor Burden | Dose-Response Relationship, Drug | B7-H1 Antigen - metabolism | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Nivolumab | Carcinoma, Hepatocellular - pathology | Biomarkers, Tumor - metabolism | Female | Liver Neoplasms - pathology | Aged | Virus diseases | Medical colleges | Care and treatment | Cell death | College teachers | Hepatoma | Comparative analysis | Drug approval | Therapy | Pemphigoid | Intravenous administration | Inhibitor drugs | PD-1 protein | Funding | Liver | Clinical trials | Hepatocellular carcinoma | Lymphocytes T | Infections | Metastasis | Dosage | Cancer therapies | B7 antigen | Acceptability | Incidence | Hepatitis | Liver cancer | Pathways | Quality | Immunotherapy | Safety management | Safety | Expansion | Drug dosages | Liver diseases | Effectiveness | Mortality | Group dynamics | Patients | Hospitals | Inhibitors | Immune checkpoint | Adults | Solid tumors | Hepatitis C virus | Hepatitis C | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Transarterial Chemoembolization and Radioembolization
by Sangro, Bruno and Salem, Riad
Seminars in liver disease, ISSN 0272-8087, 11/2014, Volume 34, Issue 4, pp. 435 - 443
radioembolization | selective internal radiation therapy | yttrium | transarterial chemoembolization | drug-eluting bead transarterial chemoembolization | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Treatment Outcome | Liver Neoplasms - therapy | Embolization, Therapeutic - adverse effects | Patient Selection | Liver Neoplasms - blood supply | Carcinoma, Hepatocellular - pathology | Carcinoma, Hepatocellular - blood supply | Chemoembolization, Therapeutic - adverse effects | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - therapy | Radiopharmaceuticals - adverse effects | Embolization, Therapeutic - methods | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectives
by Salem, Riad and Mazzaferro, Vincenzo and Sangro, Bruno
Hepatology (Baltimore, Md.), ISSN 0270-9139, 12/2013, Volume 58, Issue 6, pp. 2188 - 2197
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Chemoembolization, Therapeutic - methods | Liver Transplantation | Humans | Liver Neoplasms - radiotherapy | Middle Aged | Carcinoma, Hepatocellular - radiotherapy | Male | Aged | Clinical Trials as Topic | Yttrium Radioisotopes - therapeutic use | Index Medicus | radioembolization | randomized trial | hepatocellular carcinoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Chemoembolization and radioembolization
by Sangro, Bruno, MD, PhD
Baillière's best practice & research. Clinical gastroenterology, ISSN 1521-6918, 2014, Volume 28, Issue 5, pp. 909 - 919
Gastroenterology and Hepatology | Radioembolization, RE | Yttrium | Transarterial chemoembolization, TACE | Drug-eluting beads, DEB | Selective Internal Radiation Therapy, SIRT | DEB | Selective internal radiation therapy | Transarterial chemoembolization | TACE | Drug-eluting beads | Radioembolization | SIRT | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Radiopharmaceuticals - administration & dosage | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Humans | Embolization, Therapeutic - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Evidence-based integration of selective internal radiation therapy into hepatocellular carcinoma management
by Sangro, Bruno
Future oncology (London, England), ISSN 1479-6694, 11/2014, Volume 10, Issue 15, pp. 7 - 11
selective internal radiation therapy | hepatocellular carcinoma | brachytherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Evidence-Based Practice | Chemoembolization, Therapeutic | Humans | Liver Neoplasms - radiotherapy | Brachytherapy - methods | Carcinoma, Hepatocellular - pathology | Carcinoma, Hepatocellular - radiotherapy | Liver Neoplasms - pathology | Palliative Care | Disease Management
Journal Article
Details